Yearly Archives: 2021

Pfizer’s next multibillion-dollar covid vaccine move

Pfizer (NYSE: PFE) Earlier this year the company made a clever decision in its long history. He chose to partner with German Biotech Biotech (Nasdaq: BNTX) On the development and commercialization of its COVID-19 vaccine. And the rest, as they say, is history. The companies’ BNT162B2 COVID-19 vaccine became the …

Read More »